Next Article in Journal
Identification and Quantification of Transient Receptor Potential Vanilloid 1 (TRPV1) in Equine Articular Tissue
Next Article in Special Issue
Meningitis Caused by Streptococcus agalactiae in Nile Tilapia (Oreochromis niloticus): Infection and Inflammatory Response
Previous Article in Journal
Pronounced Inter-Individual Variation in Plasma Cortisol Response to Fluoxetine Hydrochloride in the Pig
Previous Article in Special Issue
New Insights into Modelling Bacterial Growth with Reference to the Fish Pathogen Flavobacterium psychrophilum
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Live Feeds Used in the Larval Culture of Red Cusk Eel, Genypterus chilensis, Carry High Levels of Antimicrobial-Resistant Bacteria and Antibiotic-Resistance Genes (ARGs)

1
Programa Cooperativo de Doctorado en Acuicultura, Departamento de Acuicultura, Universidad Católica del Norte, Coquimbo 1780000, Chile
2
Laboratorio de Patobiología Acuática, Departamento de Acuicultura, Universidad Católica del Norte, Coquimbo 1780000, Chile
3
Centro AquaPacífico, Universidad Católica del Norte, Coquimbo 1780000, Chile
4
Centro i~mar, Universidad de Los Lagos, Puerto Montt 5480000, Chile
5
Laboratorio de Biotecnología, Instituto de Nutrición y Tecnología de los Alimentos (INTA), Universidad de Chile, Macul, Santiago 7810000, Chile
*
Author to whom correspondence should be addressed.
Animals 2020, 10(3), 505; https://doi.org/10.3390/ani10030505
Submission received: 19 January 2020 / Revised: 29 February 2020 / Accepted: 10 March 2020 / Published: 18 March 2020
(This article belongs to the Special Issue Bacteria-Related Diseases in Fish Species)

Abstract

:

Simple Summary

The culture of the marine fish red cusk eel Genypterus chilensis is currently considered a priority for Chilean aquaculture but low larval survival rates have prompted the need for the continuous use of antibiotics, mainly florfenicol. In this study, the role of live prey (rotifers and the brine shrimp Artemia franciscana) used to feed fish larvae as a source of antibacterial-resistant bacteria in a commercial culture of G. chilensis was investigated. Samples of live feeds were collected during the larval growth period and their bacterial contents were determined. High levels of potentially opportunistic pathogens, such as Vibrio spp., as well as florfenicol-resistant bacteria, were detected. Sixty-five florfenicol-resistant isolates were recovered from these cultures and identified as Vibrio (81.5%) and Pseudoalteromonas (15.4%), which exhibited a high incidence of co-resistance to the antibiotics streptomycin, oxytetracycline, co-trimoxazole, and kanamycin. The majority of them carried the florfenicol-resistance encoding genes floR and fexA. The high prevalence of antibiotic-resistant bacteria and the associated genetic elements in live feed administered to reared fish larvae requires the prompt implementation of efficient management strategies to prevent future therapy failures in fish larval cultures and the spread of antibiotic-resistant bacteria to associated aquatic environments.

Abstract

The culture of red cusk eel Genypterus chilensis is currently considered a priority for Chilean aquaculture but low larval survival rates have prompted the need for the continuous use of antibacterials. The main aim of this study was to evaluate the role of live feed as a source of antibacterial-resistant bacteria in a commercial culture of G. chilensis. Samples of rotifer and Artemia cultures used as live feed were collected during the larval growth period and culturable bacterial counts were performed using a spread plate method. Rotifer and Artemia cultures exhibited high levels of resistant bacteria (8.03 × 104 to 1.79 × 107 CFU/g and 1.47 × 106 to 3.50 × 108 CFU/g, respectively). Sixty-five florfenicol-resistant isolates were identified as Vibrio (81.5%) and Pseudoalteromonas (15.4%) using 16S rRNA gene sequence analysis. A high incidence of resistance to streptomycin (93.8%), oxytetracycline (89.2%), co-trimoxazole (84.6%), and kanamycin (73.8%) was exhibited by resistant isolates. A high proportion of isolates (76.9%) carried the florfenicol-resistance encoding genes floR and fexA, as well as plasmid DNA (75.0%). The high prevalence of multiresistant bacteria in live feed increases the incidence of the resistant microbiota in reared fish larvae, thus proper monitoring and management strategies for live feed cultures appear to be a priority for preventing future therapy failures in fish larval cultures.

1. Introduction

The current trend in Chilean marine aquaculture is toward the diversification of cultured aquatic species. The priority is to develop the culture of native marine fish species, in particular, the red cusk eel (Genypterus chilensis), which is a Chilean native species of high gastronomic demand and market value. Consequently, it has been identified as a good candidate for production on a commercial scale. Until now, biological studies of the red cusk eel have focused mostly on genetic diversity and population structure [1,2].
The occurrence in reared diseased G. chilensis of various opportunistic pathogens, predominantly within the genus Vibrio, including Vibrio anguillarum, Vibrio ordalii, Vibrio tapetis, and Vibrio toranzoniae species have been reported previously [3,4,5]. Furthermore, the pathogenic species Tenacibaculum dicentrarchi was detected in this fish species [6]. However, studies on the sanitary conditions during the culture of red cusk eel, including administered live feed during the larval stage are not available, despite the recognized importance of live feed as an important source of bacterial contaminants in marine fish larval cultures [7,8,9].
Live prey used to feed reared marine larval fish (rotifer Brachionus plicatilis and brine shrimp Artemia franciscana), as well as intensive rearing conditions, are the main causes for the proliferation of bacteria, which could be responsible for the reduced growth and increased mortality of reared larvae [10,11,12,13]. As was previously noted by Vallés et al. [14], as soon as fish larvae start to capture and ingest live prey, larvae bacterial levels increase exponentially, with Vibrio species being the main component of the gut microbiota that are mainly derived from live prey [15,16]. Furthermore, the oral infection of larval fish through live feed has been demonstrated [17]. Live prey carries a large diversity of associated microbiota that, although they are not pathogenic to live prey, can be transferred to the larval culture, causing detrimental effects [18,19]. The dominant bacterial groups in rotifers are Vibrio, Pseudomonas, and Aeromonas, which account for 107 colony forming units (CFU) per mL in the rearing water or 104–105 CFU per rotifer [8,20,21], with similar bacterial levels observed in Artemia [22]. In another study, Vibrio was found to be the dominant genus in rotifer cultures, constituting up to 56% of the bacterial community, with Vibrio anguillarum, Vibrio alginolyticus, Vibrio diazotrophicus, Vibrio mediterranei, and Vibrio tubiashii-like as representative species [8].
Similarly, several investigators have reported that Vibrionaceae are the most common members of the gut flora of feeding larvae [23,24,25]. Grisez et al. [26] reported that the incidence of non-Vibrio taxa during the first weeks of larval development was as high as the incidence of vibrios because the digestive tract was not yet sufficiently developed to produce selective conditions.
The importance of bacterial content in the live feed used to feed marine fish larvae under rearing conditions has prompted the need for the development of various strategies to improve the sanitary quality of live feed [27,28,29]. Different bacterial control measures, such as chemical and physical disinfection, use of antibiotics, and the addition of microalgae or probiotics have been studied [30,31,32,33,34,35,36]. In various studies, probiotic strains were proven to be highly effective against pathogens and/or significantly enhance the growth of rotifers and fish larvae [37,38,39,40,41,42].
It must be noted that the use of antibiotics to treat live feed used in fish larval culture is commonplace but their efficacy is clearly species-specific and variable. Additionally, the selection of drug-resistant bacteria in treated live feed has been reported previously [43].
The use of antibiotics as prophylactic agents to control bacterial contaminants in live feed is a routine practice in Chilean larval aquaculture. Among the antibiotics currently approved for use in Chilean aquaculture, florfenicol was by far the most frequently used during 2016, accounting for 82.5% of the antibiotics used in salmon farming [44], and is currently the most used antibacterial agent in marine larval cultures. Due to the intensive and widespread use of this antibiotic, florfenicol resistance has increased in aquaculture settings [45,46,47]. Furthermore, the observation that many of the genes encoding for phenicol resistance reside on mobile genetic elements, including plasmids [46,48], which usually carry other resistance determinants [46,48], the co-selection and persistence of these resistance genes may occur through the use of other antimicrobial agents. In addition, other mechanisms of gene transfer, besides plasmid transfer, in the dissemination of antibacterial resistance among bacteria from fish farm environments have been suggested [49]. Knowledge of the prevalence of antibacterial-resistant bacteria and associated antibiotic-resistance genes (ARGs) is essential for the proper design of control strategies to improve the sanitary quality of live feed and to reduce the risk of introducing high levels of antibacterial-resistant bacteria, which could act as opportunistic pathogens for reared fish larvae. However, studies on the occurrence of antibacterial resistance among bacteria carried by live-feed cultures are still very scarce.
To our knowledge, no studies have previously been performed on the bacterial content of live feed used to feed reared marine fish larvae in Chile, including red cusk eel G. chilensis, which is currently considered a priority for Chilean aquaculture. Thus, this study will add important information on the sanitary status of live feeds and the impact of using florfenicol on the bacterial content of live-feed cultures. It could be concluded that medication of administered live feed severely increased the levels of antibiotic-resistant bacteria and related ARGs in rotifer and Artemia cultures, resulting in an important risk to reared fish larvae.
The main aim of the study was to evaluate the role of unmedicated and florfenicol-medicated live feed administered in a commercial larval culture of red cusk eel G. chilensis as an important source of antibacterial-resistant bacteria, along with the main genes encoding for florfenicol-resistance.

2. Materials and Methods

2.1. Ethics Statement

The study does not need ethical approval.

2.2. Live-Feed Culture Sampling

A commercial hatchery was included in the study for the culture of red cusk eel, G. chilensis, belonging to Colorado Chile S.A., located approximately 5 km south of Coquimbo at the southern end of La Herradura Bay on the Pacific coast of Chile. The experimental units deployed in the commercial hatchery consisted of two untreated tanks (rotifer B. plicatilis and brine shrimp A. franciscana nauplii), and additionally duplicated tanks of A. franciscana cultures treated once a day with florfenicol (final concentration of 20 mg/L). The length of the larval stage of the reared G. chilensis raised with live feed organisms was approximately 60 days post hatching (dph) (Figure 1). Live-feed samples were collected from duplicated culture tanks (600 L at a concentration of 200,000 rotifers per L and 10 L at a concentration of 1,000,000 naupli per L for the rotifer and Artemia cultures, respectively) immediately before feeding the reared fish larvae. Samples were taken at 6, 18, and 32 dph during the growth phase in which the larvae were fed with live feed and before feeding with artificial diets (Figure 1).
For comparative purposes, rotifer and Artemia cultures were collected from massive cultures developed in the commercial hatchery. Duplicated cultures were treated with florfenicol (final concentration of 20 mg/L for 2 h), whereas other duplicated untreated cultures were used as untreated controls. After 2 h of exposure, samples from the untreated and florfenicol-treated cultures were collected, placed on ice, immediately transported to the laboratory, and processed within 1 h after collection.

2.3. Sample Processing and Culturable Bacterial Count

Live feed cultures were retained on a 65-µm mesh, aseptically concentrated and collected using sterile Falcon tubes (approximately a volume of five mL of concentrated live prey), centrifuged at 4700× g for 10 min, and the supernatants were eliminated with a micropipette. The pellets obtained were aseptically weighed and ground by hand using a sterile glass digester with 1 mL of sterile physiological saline (0.85%) (PS) added to obtain a homogenate. Appropriate 10-fold dilutions of the homogenates in PS were prepared and 0.1-mL aliquots were inoculated in triplicate onto agar plates. Culturable counts of heterotrophic and florfenicol-resistant bacteria were determined using a spread plate method with Plate Count Agar (PCA, Becton Dickinson, Sparks, MD, USA), with 2% NaCl added, whereas Vibrio spp. counts were determined using Thiosulfate-Citrate-Bile Salts Sucrose agar (TCBS, Becton Dickinson, Sparks, MD, USA) prepared using 50% microfiltered (0.22 µm) aged seawater [50]. Plates with added florfenicol (30 µg/mL, Sigma-Aldrich® (St. Louis, MD, USA) were used to determine the florfenicol-resistant bacteria [50,51]. All plates were incubated at 22 °C for 5 days and the bacterial numbers per gram of sample were calculated as described in Miranda and Rojas [51].

2.4. Bacterial Isolates

A total of 65 florfenicol-resistant Gram-negative bacilli were recovered from live feed (27 and 38 isolates from rotifer and Artemia cultures, respectively) during the assay as well as from various cultures routinely developed in the hatchery during the period 2018–2019. Isolates were recovered using plates with Tryptic soy agar (TSA, Becton Dickinson, Sparks, MD, USA) containing florfenicol (30 μg/mL) and incubated at 22 °C for 5 days. Isolates were stored at −85 °C in CryoBankTM vials (Mast Diagnostica, Reinfeld, Germany) and were grown in Trypticase soy agar (TSA) at 22 °C for 24 h prior to use.

2.5. Bacterial Identification

The Gram staining, cell morphology, oxidase production, oxidation/fermentation (O/F) of glucose, growth on thiosulfate-citrate-bile salts sucrose (TCBS) agar, and susceptibility to the vibriostatic agent O/129 (2,4-diamino-6,7-diisopropylpteridine) (10 and 150 µg per disc) phenotypic tests were conducted according to the procedures described in Buller [52] using media supplemented with NaCl (2%). Furthermore, antimicrobial-resistant isolates were identified using bacterial 16S rRNA gene sequence analysis. For amplification of the 16S rRNA genes, isolates were cultured in Tryptic soy broth (Oxoid, Hants, UK) at 22 °C for 12–24 h and centrifuged at 9000× g for 3 min using an Eppendorf 5415D (Eppendorf AG, Hamburg, Germany) microcentrifuge to obtain a pellet. DNA extraction was carried out using the Wizard® Genomic DNA Purification commercial kit (Promega, Madison, WI, USA) following the supplier’s instructions, and the obtained DNA samples were stored at −20 °C until analysis. The amplification of the 16S ribosomal genes of the isolates was carried out using PCR, following the methodology described by Opazo et al. [53]. The resulting amplified PCR products were sequenced with Macrogen (Rockville, MD, USA) using the ABI PRISM 373 DNA Sequencer (Applied Biosystems, Foster City, CA, USA). The sequences were edited and matched to the Ribosomal Database Project [54] to identify the bacterial isolates.

2.6. Minimum Inhibitory Concentrations (MICs) of Florfenicol

Minimum inhibitory concentrations (MICs) of florfenicol against all isolates were determined using an agar dilution method, as recommended by the Clinical and Laboratory Standards Institute (CLSI) guideline M07-A10 [55]. A serial two-fold dilution pattern of the antibiotic was added into Mueller–Hinton agar (MH, Becton Dickinson, Sparks, MD, USA) supplemented with NaCl (2%) to obtain final concentrations ranging from 0.5 to 2048 μg/mL. Bacterial suspensions were prepared in sterile 0.85% saline and triplicate plates were inoculated using a Steers replicator apparatus [56], delivering approximately 104 colony forming units per spot, and then incubated for 48 h at 22 °C. The bacterial inocula were applied simultaneously to the agar surfaces using the inoculum-replicating apparatus capable of transferring 32 isolates onto the surface of each plate [55]. The first and last agar plates did not contain any antibiotic in order to detect possible contamination of the isolates or antibiotic carryover. The MIC was defined as the lowest concentration of the antibacterial agent that produced an absence of growth in at least two of the three plates after 48 h. A reference of strain Escherichia coli ATCC 25922, recommended by CLSI [57], was used as a quality control organism for verification of the MIC ranges on used Mueller–Hinton agar plates.

2.7. Antibacterial Resistance Patterns

The susceptibility of isolates to various antimicrobials was determined using a disk diffusion test according to the Clinical and Laboratory Standards Institute (CLSI) guideline VET3-A [57]. Briefly, the bacterial isolates were resuspended in phosphate-buffered saline (PBS) to obtain a turbidity corresponding to 0.5 McFarland standard (bioMerieux, Marcy-l’Etoile, France), corresponding to a concentration of (1–2) × 108 CFU per mL [55]. Bacterial suspensions were streaked onto plates containing Mueller–Hinton agar (MH) with 2% NaCl added, and disks (Oxoid, Basingstoke, Hampshire, England) containing the following antibiotics were used: amoxicillin (AML, 25 µg), streptomycin (S, 10 μg), kanamycin (K, 30 μg), oxytetracycline (OT, 30 μg), florfenicol (FFC, 30 μg), oxolinic acid (OA, 2 μg), flumequine (UB, 30 μg), and sulfamethoxazole trimethoprim (SXT, 25 μg). Plates were incubated at 22 °C for 24 h according to CLSI guidelines [57], and isolates were considered resistant according to the criteria established by the CLSI [58] or by Miranda and Rojas [51]. Escherichia coli ATCC 25922 was used as a quality control strain, as recommended by the CLSI [59]. Several isolates (20%) were re-examined to check the reproducibility of the assay. Furthermore, the antibacterial resistance index (ARI) of untreated and florfenicol-treated larvae cultures was determined according to Hinton et al. [60] using the formula ARI = y/nx, in which y was the actual number of resistance determinants recorded in a population of size n, and x was the total number of antibacterials tested for in the sensitivity test.

2.8. Detection of Genes Encoding for Florfenicol Resistance

All isolates were assayed for the presence of genes encoding for florfenicol resistance. The presence of the floR and fexA genes, encoding for efflux pumps, were detected using the methodology described by Fernández-Alarcón et al. [45] and Higuera-Llantén et al. [61], respectively. Primers F: 5’-AATCACGGGCCACGCTGTATC-3′ and R: 5′-CGCCGTCATTCTTCACCTTC-3′ (floR) and F: 5’-TTTCGCTGTTCTTGTGTTCG-3′ and R: 5’-ACCTTGGAAAATCCCCATTC-3′ (fexA), were used. The amplification conditions were as follows: for the floR gene, denaturation at 95 °C for 3 min; 30 cycles of denaturation at 95 °C for 30 sec, annealing at 56 °C for 30 sec, and elongation at 72 °C for 30 sec; and finally, extension at 72 °C for 7 min. For the fexA gene, denaturation at 95 °C for 3 min; 45 cycles of denaturation at 95 °C for 30 sec, annealing at 56 °C for 30 sec, and elongation at 72 °C for 30 sec; and finally, extension 72 °C for 7 min. Amplicon sizes of the floR and fexA genes were 200 and 450 bp, respectively. The amplified PCR products were sequenced using Macrogen (Rockville, MD, USA), and genes were identified using a computational analysis of the Basic Local Alignment Search Tool (BLAST) sequence alignment against the gene sequences included in the GenBank nucleotide sequence database. For the detection of floR and fexA genes, strain Citrobacter freundii FB98 carrying the floR gene [45] and a sequence of gen MH747503.1 [61], flanked by primers fexAF and fexAR synthesized using Integrated DNA Technologies (IDT, Coralville, IA, USA) were used as positive controls and were included in each PCR run.

2.9. Isolation of Plasmid DNA

Bacterial isolates were screened for their plasmid content, as previously described [62]. Briefly, the geneJET Plasmid miniprep kit (Thermo-Scientific, Waltham, MA, USA) was used and the obtained plasmid DNA was run on 1.5% agarose gel electrophoresis for plasmids less than 20 kb and 0.8% agarose gel for plasmids greater than 20 kb. Gels were stained with GelRedTM (Biotium, Hayward, CA, USA) and viewed using UV transillumination. The size was estimated via comparison with known plasmid weight standards and standard molecular weight markers.

2.10. Statistical Analysis

Culturable count values were transformed to log10, whereas proportions of florfenicol resistance were computed for each live feed (rotifers and Artemia) culture and were arcsine-transformed before analysis. One way analysis of variance (ANOVA) [63] was performed to detect significant differences (p < 0.05) between culturable counts of heterotrophic and florfenicol-resistant bacteria from control and treated live-feed cultures. Differences between untreated and florfenicol-treated cultures were detected using Student’s t-test for two independent samples [63]. In addition, all untreated and treated culture tanks were compared in a nested ANOVA analysis. When differences were statistically significant, the control and treated live feed were then compared against each other using Tukey’s test [63]. The frequencies of resistance to the assayed antimicrobials of the selected isolates were compared with Pearson’s chi-square test, adjusted with Bonferroni’s correction, and p < 0.05 was considered to indicate statistical significance. All statistical analyses were carried out using the SPSS version 12.0 computer program [64].

3. Results

3.1. Culturable Bacterial Counts

According to the current hatchery protocols, rotifer cultures are not treated with antibiotics, in contrast to the Artemia cultures, which are routinely treated with florfenicol or other antibacterial agents, thus no treated rotifer mass cultures at the red cusk eel hatchery were available during the sampling period (Table 1).
Florfenicol-resistant bacterial counts were high in both live-feed cultures during the larval growth period, ranging from 104 to 107 CFU/g of rotifer and from 106 to 108 CFU/g of Artemia (Table 1). When the florfenicol-resistant bacterial counts from both live-feed cultures were compared, levels of resistant bacteria from Artemia cultures were higher than those from rotifer cultures.
When the untreated and florfenicol-treated Artemia cultures administered after 18 and 32 days post hatching (dph) of the larval culture were compared, no important differences in heterotrophic bacterial counts were observed (Table 1). By contrast, at 18 and 32 dph of larval culture, the culturable counts of florfenicol-resistant bacteria and Vibrio spp. from florfenicol-treated Artemia cultures were significantly higher than those from the untreated Artemia cultures (Table 1). Furthermore, florfenicol-resistant bacterial counts from untreated and florfenicol treated Artemia cultures at 32 dph were higher than those from 18 dph.
Culturable counts of heterotrophic bacteria, florfenicol-resistant bacteria, and Vibrio spp. from rotifer cultures at 18 dph were lower than those from the cultures at 6 and 32 dph. Rotifer cultures exhibited their highest culturable counts of heterotrophic bacteria at 32 dph, whereas the highest counts of Vibrio spp. and florfenicol-resistant bacteria were observed at 6 and 32 dph. No important differences in the levels of culturable counts of Vibrio spp. between 6 and 32 dph were observed.
When rotifer and Artemia cultures were treated with florfenicol, bacterial culturable counts remained at high levels (105 to 107 CFU/g), indicating that florfenicol did not reduce the bacterial content in either of the live feeds, as displayed in Figure 2.
Culturable heterotrophic counts from untreated rotifer cultures were significantly higher (p = 0.007, Tukey’s test) than those observed in the florfenicol-treated cultures. On the other hand, Vibrio spp. counts from untreated rotifer samples ranged from 6.80 × 104 to 1.26 × 105 CFU/g and were significantly lower (p = 0.007, Tukey’s test) than those observed in treated rotifer culture samples (from 1.79 × 105 to 5.44 × 105 CFU/g). Otherwise, no significant differences (p = 0.065, Tukey’s test) between florfenicol-resistant bacterial counts from untreated and antibiotic-treated rotifer cultures were observed (2.66 × 106 to 3.69 × 106 CFU/g and 4.60 × 106 to 5.33 × 106 CFU/g, respectively) (Figure 2).
Untreated Artemia cultures exhibited high levels of heterotrophic bacteria, but significantly lower (p = 0.002, Tukey’s test) than those of the antibiotic-treated cultures, whereas the levels of Vibrio spp. in untreated and florfenicol-treated cultures were not significantly different (p = 0.217, Tukey’s test) (3.67 × 106 to 1.11 × 107 CFU/g and 1.72 × 106 to 1.22 × 107 CFU/g, respectively). The levels of bacteria resistant to florfenicol in samples from treated Artemia cultures were high, ranging from 1.14 × 107 to 2.90 × 107 CFU/g, and were significantly higher (p = 0.012, Tukey’s test) than those obtained from untreated Artemia cultures (6.36 × 106 to 7.09 × 106 CFU/g) (Figure 2).

3.2. Bacterial Isolates

The identification of 65 florfenicol-resistant isolates recovered from rotifer and Artemia cultures (27 and 38 isolates, respectively) used in the rearing of G. chilensis larvae showed a high predominance of Vibrio species in both rotifer and Artemia cultures (85.2% and 78.9%, respectively). In contrast, a low frequency of isolates belonging to the Pseudoalteromonas genus was found in both live-feed cultures (14.8% and 15.8%, respectively) (Table 2; Table 3).
The isolates identified as Vibrio spp. via the analysis of their 16S rRNA gene sequences shared the phenotypic properties of the genus Vibrio, including Gram-negative, glucose fermenter, oxidase-positive, susceptible to the vibriostatic agent O-129, and able to grow in TCBS agar.
The nucleotide sequences of the isolates were deposited in GenBank under the accession numbers displayed in Table 2 and Table 3.

3.3. Minimum Inhibitory Concentrations (MICs)

High levels of florfenicol resistance were observed for the isolates, with MIC values ranging from 32 to 512 µg/mL for isolates recovered from rotifer cultures (Table 4), while the MIC values of isolates from Artemia cultures ranged from 32 to 1024 µg/mL (Table 5). Lower MIC50 and MIC90 values were exhibited by isolates recovered from rotifer cultures (256 and 256 µg/mL, respectively), whereas higher MIC50 and MIC90 values (256 and 512 µg/mL, respectively) were observed for isolates from Artemia cultures. The reference strain Escherichia coli ATCC 25922 used for quality control exhibited an MIC value for florfenicol of 2 µg/mL, which agrees with the values recommended by the National Committee for Clinical Laboratory Standards (NCCLS) [65].

3.4. Antimicrobial Resistance Patterns

Similar antimicrobial resistance patterns of the recovered strains were not related to specific bacterial species or the live feed sampled. Furthermore, resistant isolates from untreated and treated cultures exhibited similar antibacterial resistance patterns, as shown in Table 4 and Table 5. Furthermore, similar antimicrobial indexes (ARI) were observed among the florfenicol-resistant bacteria isolated from both live-feed cultures, exhibiting ARI values of 0.79 and 0.71 for isolates recovered from rotifer and Artemia cultures, respectively. The majority of isolates from the rotifer and Artemia cultures exhibited multiresistance or simultaneous resistance to at least three classes of antimicrobials (24 out of 27 and 36 out of 38 isolates recovered from rotifer and Artemia cultures, respectively) (Table 4; Table 5). High levels of multiresistance among florfenicol-resistant isolates from both cultures were detected, with 70.4% of isolates from rotifer cultures exhibiting simultaneous resistance to 7–8 antimicrobials, whereas a high proportion of isolates from Artemia cultures were resistant to 5–6 antimicrobials (76.3%). The reference strain Escherichia coli ATCC 25922 used for quality control exhibited a zone diameter of inhibition of 23 mm, which agrees with the values recommended by CLSI [57].
A high proportion of florfenicol-resistant isolates recovered from rotifer and Artemia cultures exhibited resistance to the antibacterials streptomycin (93.8%), oxytetracycline (89.2%), co-trimoxazole (84.6%), and kanamycin (73.8%), and did not show significant differences between the cultures (Figure 3). In contrast, significant differences (p < 0.05) between isolates from rotifer and Artemia cultures for resistance to oxolinic acid (88.2% and 26.1%, respectively), flumequine (85.5% and 21.2%, respectively), and amoxicillin (22.6% and 76.1%, respectively) were detected (Figure 3).

3.5. Phenicol Resistance Genes

A high occurrence of the floR gene was detected among the floRfenicol-resistant isolates recovered from rotifer and Artemia cultures when compared with the occurrence of the fexA gene. A high proportion of the resistant isolates (21 out of 27 strains (77.8%)) recovered from the rotifer cultures carried the floR gene, and among them, three isolates also carried the fexA gene (Table 2). On the other hand, only one isolate carried only the fexA gene, whereas in five resistant isolates, none of the assayed genes were detected. Among the isolates recovered from the Artemia cultures, 23 out of 38 isolates (60.5%) harbored the floR gene, and among them, only one isolate (2.6%) also carried the fexA gene (2.6%). In contrast, the fexA gene was detected in only five isolates (13.2%), whereas ten isolates (26.3%) from Artemia cultures were negative for the assayed genes (Table 3). Resistant isolates carrying neither the floR nor fexA genes (5 and 10 isolates from rotifer and Artemia cultures, respectively) exhibited MIC values of 32 to 128 µg/mL for isolates from rotifer cultures, and MIC values of 32 to 1024 µg/mL for isolates from Artemia cultures.

3.6. Plasmid Content

Plasmid DNA was detected in 42 out of 59 florfenicol-resistant isolates examined, and from these, 14 and 28 isolates were recovered from rotifer and Artemia cultures, respectively (Table 2; Table 3). Interestingly, a higher number of rotifer isolates were negative for plasmid content (13 out of 27 isolates), compared to the isolates recovered from Artemia cultures (4 out of 32 assayed isolates). Among the plasmid-carrying isolates, 1 and 11 isolates from rotifer and Artemia cultures, respectively, contained two plasmid bands. The number and size of plasmid bands found are shown in Table 2 and Table 3. The majority of resistant isolates from rotifer and Artemia cultures contained plasmids with molecular weights ranging from 35 to 50 kb (12 and 29 isolates, respectively). The most commonly found plasmid bands had molecular weights of 40 and 35 kb (16 and 18 isolates) (Table 4; Table 5).

4. Discussion

Considering the high importance of florfenicol in treating and preventing bacterial infections in Chilean aquaculture, the occurrence of bacterial resistance to this compound was investigated in live feeds used in larval cultures of red cusk eel, G. chilensis, which is considered a priority for Chilean aquaculture. In addition, the presence of the main determinants conferring resistance to florfenicol and the plasmid content of the selected resistant bacteria was investigated.
To our knowledge, this is the first report on the occurrence of antimicrobial-resistant bacteria in the live feeds that are most frequently used in marine fish larvae rearing, as most of the previous studies have attempted to reduce bacterial load in these cultures [19,25,26,27,28,29] or characterize the bacterial species associated with the live feeds [7,8,9,10,11,13,15,16,18,19,43]. Our findings have demonstrated that live-feed cultures used in a Chilean commercial hatchery of red cusk eel have high levels of resistant bacteria in both untreated and treated live feeds, suggesting that the usage of florfenicol is not a necessary causal condition for the development and maintenance of elevated frequencies of florfenicol resistance. That is to say, mass-produced live feeds in the commercial hatchery never exposed to antibacterial therapy exhibited high levels of florfenicol-resistant bacteria. Thus, the well-accepted paradigm that a selective pressure is needed for the selection and persistence of antibacterial resistance in marine fish aquaculture is not supported. Previous findings obtained from a Chilean scallop hatchery, in which high levels of antibacterial resistant bacteria were detected in untreated scallop larvae [66], did support the paradigm.
In commercial hatchery operations, the practice of rotifer batch cultivation characterized by high rotifer densities and high loads of organic matter favors the proliferation of copiotrophic bacteria, such as Vibrio spp. Antibacterial treatments were shown to be ineffective at reducing the bacterial load in live feed, and they may even increase the occurrence of vibrios exhibiting antibacterial resistance. In this study, treatments of live-feed cultures with florfenicol were not able to reduce the bacterial load, but most probably led to the emergence of antibiotic-resistant bacteria, thus impeding the establishment of normal non-pathogenic bacteria.
The high levels of florfenicol-resistant bacteria in both live feeds used in marine fish larval culture indicates a widespread antibacterial resistance within the microbiota associated with red cusk eel farming. As was observed, live-feed cultures treated with florfenicol exhibited no significant reductions in their bacterial content and resistant bacteria, and most of the culturable levels observed during the fish larval rearing period remained high (>106 CFU/g). In a previous study, no significant differences (p < 0.05) in the culturable counts of heterotrophic bacteria and Vibrio spp. between untreated and oxolinic-acid-treated rotifer cultures were observed, resulting in the conclusion that antibiotic-treated rotifers used to feed reared larvae of blue-fin seabream are not needed to improve larval survival [67]. By contrast, the bacterial loads on both rotifers and Artemia were reduced with antibiotics [10], but until now, effective bacterial reduction in mass-produced rotifers remains an unsolved issue. Having previously reported that the use of rotifers with reduced bacterial load improved the survival of turbot larvae during first feeding [10], it appears to be highly important to reduce the bacterial load of the rotifer culture prior to use in red cusk eel culture.
However, it is important to consider that variations in several aspects of florfenicol administration in live feeds, such as the purity of antibiotic used, administered concentration by volume, and routes and frequency of administration of florfenicol could preclude the efficacy of antibiotic treatment to significantly reduce bacterial loads in live feeds. To date, there exists only one study of the use of florfenicol that reduced the bacterial load in Artemia culture, using a dose of 300 mg/L of florfenicol and resulting in an important reduction of Vibrio counts. In this study, when florfenicol was administered, Vibrio counts were reduced from 1.20 × 109 ± 9.00 × 108 CFU/g to 2.00 × 105 ± 7.00 × 104 CFU/g and from 4.50 × 108 ± 2.40 × 108 CFU/g to 3.10 × 107 ± 7.00 × 106 CFU/g of Artemia nauplii (capsulated and decapsulated cysts, respectively) [68]. However, the potentially pathogenic species, V. alginolyticus and V. parahaemolyticus remained in the treated Artemia naupli [68]. Vibrio counts of treated Artemia observed in this study were similar to those observed in Artemia nauplii (decapsulated cysts), but lower than those observed in capsulated cysts in the previous study; however, it must be noted that in this study, a much lower concentration of florfenicol was administered (20 mg/L versus 300 mg/L).
Despite the previous observations, antibiotic treatment can reduce bacterial load in live feeds but cannot prevent the live feeds from being recolonized within a short period [27], thus suggesting the need to find other therapeutic alternatives. In addition, well-documented toxic effects of florfenicol on fish and crustacean larvae [69,70,71,72] indicate the urgent need for considering the use of alternative strategies to control pathogenic bacteria in live feeds administered to marine fish aquaculture, including bacteriophages, probiotics, and natural products [42,73,74]. In a recent study, probiotics, organic acids, and essential oils were demonstrated to be effective at controlling the pathogenic activity of vibrios on A. franciscana nauplii [75]. Thus, using live feeds as carriers for non-antibiotic therapeutic applications in marine fish cultures appears to be a very attractive option.
It has been argued that live feeds carry a low diversity of associated antibiotic-resistant microbiota, composed mostly of vibrios, which are most probably transferred to the fish larval culture, causing detrimental effects on the reared larvae [10,11]. Although no information on florfenicol-resistant species associated with live feeds used in marine fish larval culture is currently available, the dominance of Vibrio observed in this study are in accordance with other studies showing Vibrio species as the dominant component of the microbiota in the routine production of the rotifer Brachionus plicatilis [8,76]. Furthermore, in a previous study, Vibrio spp. were reported as the main constituents of the bacterial microbiota in the gut of the turbot larvae, and the authors concluded they were probably introduced by the rotifers [11].
Although phylogenetic analysis based on 16S rRNA gene sequences confirmed that 53 out of 65 isolates belonged to the genus Vibrio, 16S rRNA sequence analysis is unable to resolve closely related species, such as those clustered in the Vibrio group [77]. In this study, most of the studied isolates identified as Vibrio spp. (41 out of 53 isolates) exhibited low percentages of identity (≤99.8%). Thus, resistant isolates were identified only to the genus level, and further analysis, such as multilocus sequence analysis (MLSA) using various housekeeping genes or whole-genome sequencing (WGS), is required to accurately define the taxonomic affiliations of Vibrio isolates, especially at the species level [78,79].
This study demonstrated that live feed is a main source of antibiotic-resistant Vibrio in the red cusk eel culture, which is a highly significant risk to the health status of reared fish larvae fed with rotifer and Artemia considering that previous studies have demonstrated the pathogenic role of various Vibrio species in the experimental culture of this species in Chile [3,4,5]. However, further studies are required to elucidate the impact on the microbiota of the larvae reared using these live feeds.
To our knowledge, no studies of resistant microbiota and the associated antibiotic-resistance genes (ARGs) of reared marine fish in Chile have been undertaken despite the intensive use of antibiotics in this industry, which are mainly used in the larval culture and the role of live feeds as carriers of bacteria to reared fish larvae. However, the prevalence and concentration of ARGs, as well as their sources and spreading pathways in marine aquaculture, are little understood. Thus, the incidence of antibacterial resistance and the characterization of related genes is an urgent necessity for this industry, but information on the occurrence of resistance genes in farmed marine fish species in Chile is still very scarce.
As was previously described [46], bacterial resistance to florfenicol is primarily mediated by the floR gene, which is a specific drug exporter that confers resistance to florfenicol and chloramphenicol [80], and is widely disseminated among Gram-negative bacteria from animal agricultural sources [81,82,83]. The presence of floR has previously been reported in bacteria isolated from mucus and intestinal contents of farmed salmon, as well as lake water and sediments associated with salmon farming in Chile [45,61]. However, this is the first report of the presence of floR and fexA genes in non-salmonid marine fish aquaculture in Chile. It is interesting to note the high incidence of the floR gene among isolates recovered from both live-feed cultures (67.7%) is in accordance with isolates recovered from freshwater and marine environments impacted by salmon farms in Chile [45,61]. Furthermore, this is the first report of floR- and fexA-carrying Vibrio spp. isolated from live feed used in marine fish larval culture, prompting the necessity of implementing continuous monitoring and sanitary control of live feeds to avoid the spread of these resistance genes in the hatchery.
Furthermore, in a previous study, the fexA gene was detected in a high number of bacteria, which were mainly identified as Pseudomonas and were recovered from the fecal content of salmon reared in a Chilean marine farm that made intensive use of antibacterials [61], contrasting with the low occurrence of fexA-carrying isolates observed in this study. These authors concluded that the gut microbiota of medicated farmed salmon could serve as a perfect reservoir for genes encoding for resistance to florfenicol, such as floR and fexA [61], but that these genes had not thus far been reported in non-salmonid farmed species.
From this study, a high number of isolates exhibited a co-resistance to oxytetracycline, the second-most frequently used antibacterial in Chilean aquaculture. This concurs with previous studies that have reported an association of the floR gene with tetracycline resistance. Dang et al. [84] detected the floR gene associated with several tetracycline-resistant isolates from aquaculture in China, whereas Gordon et al. [83] found that the floR gene was linked to a tetracycline resistance gene in an Aeromonas bestiarum isolate recovered from a freshwater environment. This fact might preclude the efficacy of the therapeutic use of oxytetracycline in marine fish larval culture.
Considering that none of the assayed resistance genes were detected in 39.5% of the studied florfenicol-resistant isolates, we could conclude that other mechanisms, such as enzymes or other exporter systems, could be responsible for the exhibited resistance; however, further research is required to elucidate the mechanisms conferring the florfenicol resistance detected in these isolates.
Finally, florfenicol-resistance-encoding genes, mainly floR, have frequently been associated with plasmids carried by human and animal pathogenic bacteria [85,86,87,88,89], thus the co-presence of this gene and plasmid elements in a high number of the studied isolates (71.2%) provides very favorable conditions for the genetic exchange among bacteria comprising the live feed and fish larval gut microbiota. This increases the feasibility of the spread of florfenicol-encoding genes to bacterial pathogens. However, the ability of detected plasmids and florfenicol-encoding genes to be transferred horizontally was not addressed in this study and remains to be investigated to properly determine the potential risk of transfer of these elements to the fish larvae microbiota.
Thus, it is critical for the marine fish aquaculture industry in Chile to monitor the emergence and spread of resistance to florfenicol and the associated main components of the resistome and mobilome to avoid future therapy failures in marine fish larval cultures.

5. Conclusions

The results of this study have demonstrated that live feed administered to reared larvae played an important role as a major source of antimicrobial-resistant bacteria and associated determinants in the commercial culture of red cusk eel larvae. In addition, the study revealed that florfenicol-resistant microbiota from live feed administered to reared fish larvae mainly belonged to the Vibrio and Pseudoalteromonas genera and that they exhibited co-resistance to oxytetracycline, streptomycin, and co-trimoxazole. Furthermore, the high prevalence of plasmids among floR-carrying bacteria suggests that these bacteria may contribute to the increased spread of bacterial resistance to florfenicol and other antibacterials in environments associated with these cultures.

Author Contributions

Conceptualization, C.D.M.; methodology, L.H., R.R., and F.A.G.; software, R.R. and J.R.; validation, R.R. and C.D.M.; formal analysis, L.H., R.R., F.A.G., and M.A.A.; investigation, L.H., R.R., F.A.G., M.A.A., and J.R.; resources, C.D.M. and R.R.; writing—original draft preparation, C.D.M. and F.A.G..; writing—review and editing, C.D.M. and F.A.G.; visualization, C.D.M.; supervision, C.D.M. and J.R.; project administration, C.D.M.; funding acquisition, C.D.M. All authors have read and agreed to the published version of the manuscript.

Funding

This study was funded by the Science and Technology National Council (CONICYT) of Chile, grant number 1171772, and partially by the CORFO, Project 15PTE-C47381. L.H. is a student in the Doctoral Program in Aquaculture at the Universidad Católica del Norte and was supported by the CONICYT Doctoral Fellowship, grant number 21151482. M.A.A. was supported by the productivity improvement program of the Master of Sciences of the Universidad de Los Lagos.

Acknowledgments

The authors acknowledge Piero Magnolfi and all staff of the Colorado Chile company for providing facilities, materials, and support to develop control and treated live-feed cultures, as well as for good collaboration with live-feed culture maintenance and sampling collection. We thank Dr. Matthew Lee, Centro i∼mar, Universidad de Los Lagos, Puerto Montt, Chile, for editing the manuscript.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Jara-Seguel, P.; Ubilla, A.; Estrada, J.M.; Ramírez, D.; Valdebenito, I. Nuclear DNA content in the red conger eel Genypterus chilensis (Guichenot, 1881) (Actinopterygii: Ophidiidae). Gayana 2011, 75, 198–200. [Google Scholar] [CrossRef] [Green Version]
  2. Córdova-Alarcón, V.R.; Araneda, C.; Jilberto, F.; Magnolfi, P.; Toledo, M.I.; Lam, N. Genetic Diversity and Population Structure of Genypterus chilensis, a Commercial Benthic Marine Species of the South Pacific. Front. Mar. Sci. 2019, 6, 748. [Google Scholar] [CrossRef] [Green Version]
  3. Levican, A.; Avendaño-Herrera, R. Bacteria associated with mass mortality of post-larvae of red conger eel (Genypterus chilensis) cultured in a Chilean farm. Bull. Eur. Assoc. Fish Pathol. 2015, 35, 162–169. [Google Scholar]
  4. Lasa, A.; Avendaño-Herrera, R.; Estrada, J.M.; Romalde, J.L. Isolation and identification of Vibrio toranzoniae associated with diseased red conger eel (Genypterus chilensis) farmed in Chile. Vet. Microbiol. 2015, 179, 327–331. [Google Scholar] [CrossRef]
  5. Levican, A.; Lasa, A.; Irgang, R.; Romalde, J.L.; Poblete-Morales, M.; Avendaño-Herrera, R. Isolation of Vibrio tapetis from two native fish species (Genypterus chilensis and Paralichthys adspersus) reared in Chile and description of Vibrio tapetis subsp. quintayensis subsp. nov. Int. J. Syst. Evol. Microbiol. 2017, 67, 716–723. [Google Scholar] [CrossRef]
  6. Irgang, R.; González-Luna, R.; Gutíerrez, J.; Poblete-Morales, M.; Rojas, V.; Tapia-Cammas, D.; Avendaño-Herrera, R. First identification and characterization of Tenacibaculum dicentrarchi isolated from Chilean red conger eel (Genypterus chilensis, Guichenot 1881). J. Fish Dis. 2017, 40, 1915–1920. [Google Scholar] [CrossRef]
  7. Verdonck, L.; Swings, J.; Kersters, K.; Dehasque, M.; Sorgeloos, P.; Leger, P. Variability of the microbial environment of rotifer Brachionus plicatilis and Artemia production systems. J. World Aquac. Soc. 1994, 25, 55–59. [Google Scholar] [CrossRef]
  8. Verdonck, L.; Grisez, L.; Sweetman, E.; Minkoff, I.G.; Sorgeloos, P.; Ollevier, F.; Swings, J. Vibrios associated with routine productions of Brachionus plicatilis. Aquaculture 1997, 149, 203–214. [Google Scholar] [CrossRef]
  9. Rombaut, G.; Suantika, G.; Boon, N.; Maertens, S.; Dhert, P.; Top, E.; Sorgeloos, P.; Verstraete, W. Monitoring of the evolving diversity of the microbial community present in rotifer cultures. Aquaculture 2001, 198, 237–252. [Google Scholar] [CrossRef]
  10. Pérez-Benavente, G.P.; Gatesoupe, F.J. Bacteria associated with cultured rotifers and Artemia are detrimental to larval turbot, Scophthalmus maximus L. Aquac. Eng. 1988, 7, 289–293. [Google Scholar] [CrossRef]
  11. Nicolas, J.L.; Robic, E.; Ansquer, D. Bacterial flora associated with a trophic chain consisting of microalgae, rotifers, and turbot larvae: Influence of bacteria on larval survival. Aquaculture 1989, 83, 237–248. [Google Scholar] [CrossRef]
  12. Orozco-Medina, C.; Maeda-Martínez, A.; López-Cortés, A. Effect of aerobic Gram-positive heterotrophic bacteria associated with Artemia franciscana cysts on the survival and development of its larvae. Aquaculture 2002, 213, 15–29. [Google Scholar] [CrossRef]
  13. Kumaran, T.; Citarasu, T. Isolation and Characterization of Vibrio Species from Shrimp and Artemia Culture and Evaluation of the Potential Virulence Factor. Intel. Prop. Rights 2016, 4, 153. [Google Scholar] [CrossRef] [Green Version]
  14. Vallés, R.; Roque, A.; Caballero, A.; Estévez, A. Use of Ox-Aquaculture© for disinfection of live prey and meagre larvae, Argyrosomus regius (Asso, 1801). Aquac. Res. 2015, 46, 413–419. [Google Scholar] [CrossRef]
  15. Skjermo, J.; Vadstein, O. Characterization of the bacterial flora of mass cultivated Brachionus plicatilis. Hydrobiologia 1993, 255, 185–191. [Google Scholar] [CrossRef]
  16. Verschuere, L.; Dhont, J.; Sorgeloos, P.; Verstraete, W. Monitoring Biolog patterns and r/K-strategists in the intensive culture of Artemia juveniles. J. Appl. Microbiol. 1997, 83, 603–612. [Google Scholar] [CrossRef]
  17. Grisez, L.; Chair, M.; Sorgeloos, P.; Ollevier, F. Mode of infection and spread of Vibrio anguillarum in turbot (Scophthalmus maximus) larvae after oral challenge through live feed. Dis. Aquat. Org. 1996, 26, 181–187. [Google Scholar] [CrossRef]
  18. Dhert, P.; Rombaut, G.; Suantika, G.; Sorgeloos, P. Advancement of rotifer culture and manipulation techniques in Europe. Aquaculture 2001, 200, 129–146. [Google Scholar] [CrossRef] [Green Version]
  19. Giménez, G.; Padrós, F.; Roque, A.; Estévez, A.; Furones, D. Bacterial load reduction of live prey for fish larval feeding using Ox-Aquaculture©. Aquac. Res. 2006, 37, 1130–1139. [Google Scholar] [CrossRef]
  20. Jayasree, L.; Sonali, S.M.; Purbali, S.; Philipose, K.K. Bacterial Flora of Water and Rotifers in Outdoor Mass Culture Tanks Fed with Different Microalagal Diets. J. Life Sci. 2016, 10, 123–127. [Google Scholar] [CrossRef] [Green Version]
  21. Prol-Garcia, M.J.; Planas, M.; Pintado, J. Different Colonization and Residence Time of Listonella anguillarum and Vibrio splendidus in the Rotifer Brachionus plicatilis Determined by Real-time PCR and DGGE. Aquaculture 2010, 302, 26–35. [Google Scholar] [CrossRef]
  22. Austin, B.; Allen, B.W. Microbiology of laboratory-hatched brine shrimp (Artemia). Aquaculture 1981, 26, 369–383. [Google Scholar] [CrossRef]
  23. Reid, H.I.; Treasurer, J.W.; Adam, B.; Birkbeck, T.H. Analysis of bacterial populations in the gut of developing cod larvae and identification of Vibrio logei, Vibrio anguillarum and Vibrio splendidus as pathogens of cod larvae. Aquaculture 2009, 288, 36–43. [Google Scholar] [CrossRef]
  24. Egerton, S.; Culloty, S.; Whooley, J.; Stanton, C.; Ross, R.P. The Gut Microbiota of Marine Fish. Front. Microbiol. 2018, 9, 873. [Google Scholar] [CrossRef] [PubMed]
  25. Vadstein, O.; Attramadal, K.J.K.; Bakke, I.; Forberg, T.; Olsen, Y.; Verdegem, M.; Giatsis, C.; Skjermo, J.; Aasen, I.M.; Gatesoupe, F.-J.; et al. Managing the Microbial Community of Marine Fish Larvae: A Holistic Perspective for Larviculture. Front. Microbiol. 2018, 9, 1820. [Google Scholar] [CrossRef] [PubMed]
  26. Grisez, L.; Reyniers, J.; Verdonck, L.; Swings, J.; Ollevier, F. Dominant intestinal microflora of sea bream and sea bass larvae, from two hatcheries, during larval development. Aquaculture 1997, 155, 387–399. [Google Scholar] [CrossRef]
  27. Gómez-Gil, B.; Abreu-Grobois, F.A.; Romero-Jarero, J.; Herrera-Vega, M. Chemical disinfection of Artemia nauplii. J. World Aquac. Soc. 1994, 25, 579–583. [Google Scholar] [CrossRef]
  28. Martínez-Díaz, S.F.; Álvarez-González, C.A.; Moreno Legorreta, M.; Vázquez-Juárez, R.; Barrios-González, J. Elimination of the associated microbial community and bioencapsulation of bacteria in the rotifer Brachionus plicatilis. Aquac. Int. 2003, 11, 95–108. [Google Scholar] [CrossRef]
  29. Munro, P.D.; Henderson, R.J.; Barbour, A.; Birkbeck, T.H. Partial decontamination of rotifers with ultraviolet radiation: The effect of changes in the bacterial load and flora of rotifers on mortalities in start-feeding larval turbot. Aquaculture 1999, 170, 229–244. [Google Scholar] [CrossRef]
  30. Douillet, P.A. Bacterial additives that consistently enhance rotifer growth under synxenic culture conditions. 2. Use of single and multiple bacterial probiotics. Aquaculture 2000, 182, 241–248. [Google Scholar] [CrossRef]
  31. Verschuere, L.; Rombaut, G.; Sorgeloos, P.; Verstraete, W. Probiotic bacteria as biological control agents in aquaculture. Microbiol. Mol. Biol. Rev. 2000, 64, 655–671. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  32. Gatesoupe, F.-J. Probiotic and formaldehyde treatments of Artemia nauplii as food for larval pollack, Pollachius pollachius. Aquaculture 2002, 212, 347–360. [Google Scholar] [CrossRef] [Green Version]
  33. Villamil, L.; Figueras, A.; Planas, M.; Novoa, B. Control of Vibrio alginolyticus in Artemia culture by treatment with bacterial probiotics. Aquaculture 2003, 219, 43–56. [Google Scholar] [CrossRef]
  34. Tolomei, A.; Burke, C.; Crear, B.; Carson, J. Bacterial decontamination of on-grown Artemia. Aquaculture 2004, 232, 357–371. [Google Scholar] [CrossRef]
  35. Marques, A.; Thanh, T.H.; Sorgeloos, P.; Bossier, P. Use of microalgae and bacteria to enhance protection of gnotobiotic Artemia against different pathogens. Aquaculture 2006, 258, 116–126. [Google Scholar] [CrossRef]
  36. Haché, R.; Lanteigne, C.; Hébert, Y. Salt as a decontamination agent to control bacterial load in Artemia salina cultures. Aquaculture 2006, 452, 24–27. [Google Scholar] [CrossRef]
  37. Gatesoupe, F.J.; Lambert, C.; Nicolas, J.L. Pathogenicity of Vibrio splendidus strains associated with turbot larvae, Scophthalmus maximus. J. Appl. Microbiol. 1999, 87, 757–763. [Google Scholar] [CrossRef] [Green Version]
  38. Planas, M.; Pérez-Lorenzo, M.; Hjelm, M.; Gram, L.; Uglenes Fiksdal, I.; Bergh, Ø.; Pintado, J. Probiotic effect in vivo of Roseobacter strain 27-4 against Vibrio (Listonella) anguillarum infections in turbot (Scophthalmus maximus L.) larvae. Aquaculture 2006, 255, 323–333. [Google Scholar] [CrossRef] [Green Version]
  39. D’Alvise, P.W.; Lillebø, S.; Prol-Garcia, M.J.; Wergeland, H.; Nielsen, K.F.; Bergh, Ø.; Gram, L. Phaeobacter gallaeciensis reduces Vibrio anguillarum in cultures of microalgae and rotifers, and prevents vibriosis in cod larvae. PLoS ONE 2012, 7, e43996. [Google Scholar] [CrossRef] [Green Version]
  40. Skjermo, J.; Bakke, I.; Dahle, S.W.; Vadstein, O. Probiotic strains introduced through live feed and rearing water have low colonizing success in developing Atlantic cod larvae. Aquaculture 2015, 438, 17–23. [Google Scholar] [CrossRef]
  41. Quiroz-Guzmán, E.; Vázquez-Juárez, R.; Luna-González, A.; Balcázar, J.L.; Barajas-Sandoval, D.R.; Martínez-Díaz, S.F. Administration of Probiotics Improves the Brine Shrimp Production and Prevents Detrimental Effects of Pathogenic Vibrio Species. Mar. Biotechnol. 2018, 20, 512–519. [Google Scholar] [CrossRef] [PubMed]
  42. Sahandi, J.; Sorgeloos, P.; Xiao, H.; Wang, X.; Qi, Z.; Zheng, Y.; Tang, X. The Use of Selected Bacteria and Yeasts to Control Vibrio spp. in Live Food. Antibiotics 2019, 8, 95. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  43. Haamed, A.S.; Balasubramanian, G. Antibiotic resistance in bacteria isolated from Artemia nauplii and efficacy of formaldehyde to control bacterial load. Aquaculture 2000, 183, 195–205. [Google Scholar] [CrossRef]
  44. Miranda, C.D.; Godoy, F.A.; Lee, M.R. Current Status of the Use of Antibiotics and the Antimicrobial Resistance in the Chilean Salmon Farms. Front. Microbiol. 2018, 9, 1284. [Google Scholar] [CrossRef]
  45. Fernández-Alarcón, C.; Miranda, C.D.; Singer, R.S.; López, Y.; Rojas, R.; Bello, H.; Domínguez, M.; González-Rocha, G. Detection of the floR gene in a diversity of florfenicol resistant Gram-negative bacilli from freshwater salmon farms in Chile. Zoon. Public Health 2010, 57, 181–188. [Google Scholar] [CrossRef]
  46. Roberts, M.C.; Schwarz, S. Tetracycline and Phenicol Resistance Genes and Mechanisms: Importance for Agriculture, the Environment, and Humans. J. Environ. Qual. 2016, 45, 576–592. [Google Scholar] [CrossRef]
  47. Hong, B.; Ba, Y.; Niu, L.; Lou, F.; Zhang, Z.; Liu, H.; Pan, Y.; Zhao, Y. A Comprehensive Research on Antibiotic Resistance Genes in Microbiota of Aquatic Animals. Front. Microbiol. 2018, 9, 1617. [Google Scholar] [CrossRef]
  48. Schwarz, S.; White, D.G. Phenicol Resistance. In Frontiers in Antimicrobial Resistance; White, D.G., Alekshun, M.N., McDermott, P.F., Eds.; American Society for Microbiology, ASM Press: Washington, DC, USA, 2005; pp. 124–147. [Google Scholar]
  49. Schmidt, A.S.; Bruun, M.S.; Dalsgaard, I.; Larsen, J.L. Incidence, distribution, and spread of tetracycline resistance determinants and integron-associated antibiotic resistance genes among motile aeromonads from a fish farming environment. Appl. Environ. Microbiol. 2001, 67, 5675–5682. [Google Scholar] [CrossRef] [Green Version]
  50. Miranda, C.D.; Rojas, R.; Abarca, A.; Hurtado, L. Effect of florfenicol and oxytetracycline treatments on the intensive larval culture of the Chilean scallop Argopecten purpuratus (Lamarck, 1819). Aquac. Res. 2014, 45, 16–30. [Google Scholar] [CrossRef]
  51. Miranda, C.D.; Rojas, R. Occurrence of florfenicol resistance in bacteria associated with two Chilean salmon farms with different history of antibacterial usage. Aquaculture 2007, 266, 39–46. [Google Scholar] [CrossRef]
  52. Buller, N.B. Bacteriological Culture Techniques: Microscopy, Culture and Identification. In Bacteria from Fish and Other Aquatic Animals: A Practical Identification Manual, 1st ed.; Buller, N.B., Ed.; CABI Publishing: Cambridge, MA, USA, 2004; pp. 83–116. [Google Scholar]
  53. Opazo, R.; Ortúzar, F.; Navarrete, P.; Espejo, R.; Romero, J. Reduction of soybean meal non-starch polysaccharides and α-Galactosides by solid-state fermentation using cellulolytic bacteria obtained from different environments. PLoS ONE 2012, 7, e44783. [Google Scholar] [CrossRef] [PubMed]
  54. Ribosomal Database Project. Available online: http://rdp.cme.msu.edu/ (accessed on 5 January 2020).
  55. CLSI. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically; Approved Standard, 10th ed.; M07-A10; Clinical and Laboratory Standards Institute: Wayne, NJ, USA, 2015. [Google Scholar]
  56. Steers, E.; Foltz, E.L.; Graves, B.S.; Riden, J. An inocula replicating apparatus for routine testing of bacterial susceptibility to antibiotics. Antibiot. Chemother. 1959, 9, 307–311. [Google Scholar]
  57. CLSI. Methods for Antimicrobial Disk Susceptibility Testing of Bacteria Isolated from Aquatic Animals; Approved Guideline VET03-A; Number 23; Clinical and Laboratory Standards Institute: Wayne, NJ, USA, 2006; Volume 26. [Google Scholar]
  58. CLSI. Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated from Animals, 4th ed.; CLSI Supplement VET08; Clinical and Laboratory Standards Institute: Wayne, NJ, USA, 2018. [Google Scholar]
  59. CLSI. Performance Standards for Antimicrobial Disk Susceptibility Test; Approved Standard, 12th ed.; M02-A12; Clinical and Laboratory Standards Institute: Wayne, NJ, USA, 2015. [Google Scholar]
  60. Hinton, M.; Hedges, A.J.; Linton, A.H. The ecology of Escherichia coli in market claves fed a milk-substitute diet. J. Appl. Bacteriol. 1985, 58, 27–35. [Google Scholar] [CrossRef] [PubMed]
  61. Higuera-Llantén, S.; Vásquez-Ponce, F.; Barrientos-Espinoza, B.; Mardones, F.O.; Marshall, S.H.; Olivares-Pacheco, J. Extended antibiotic treatment in salmon farms select multiresistant gut bacteria with a high prevalence of antibiotic resistance genes. PLoS ONE 2018, 13, e0203641. [Google Scholar] [CrossRef] [Green Version]
  62. Domínguez, M.; Miranda, C.D.; Fuentes, O.; de la Fuente, M.; Godoy, F.A.; Bello-Toledo, H.; González-Rocha, G. Occurrence of transferable integrons and sul and dfr genes among sulfonamide-and/or trimethoprim-resistant bacteria isolated from Chilean salmonid farms. Front. Microbiol. 2019, 10, 748. [Google Scholar] [CrossRef]
  63. Zar, J.H. Biostatistical Analysis, 4th ed.; Prentice-Hall: Upper Saddle River, NJ, USA, 1999; p. 931. [Google Scholar]
  64. Norusis, M.J. Statistical Package for the Social Sciences (SPSS) 12.0 Statistical Procedures Companion; Prentice Hall: Englewood Cliffs, NJ, USA, 2004; p. 601. [Google Scholar]
  65. NCCLS. Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated from Animals; Approved Standard—2nd ed. ; NCCLS document M31-A2; NCCLS: Wayne, PA, USA, 2002; ISBN 1-56238-461-9. [Google Scholar]
  66. Miranda, C.D.; Rojas, R.; Garrido, M.; Geisse, J.; González, G. Role of shellfish hatchery as a reservoir of antimicrobial resistant bacteria. Mar. Pollut. Bull. 2013, 74, 334–343. [Google Scholar] [CrossRef]
  67. Abu-Rezq, T.; Al-Abdul-Elah, K.; Duremdez, R.; Al-Marzouk, A.; James, C.M.; Al-Gharabally, H.; Al-Shimmari, J. Studies on the effect of using the rotifer, Brachionus plicatilis, treated with different nutritional enrichment media and antibiotics on the growth and survival of blue-fin sea bream, Sparidentex hasta (Valenciennes), larvae. Aquac. Res. 2002, 33, 117–128. [Google Scholar] [CrossRef]
  68. Interaminense, J.A.; Calazans, N.F.; Cáritas do Valle, B.; Vogeley, J.L.; Peixoto, S.; Soares, R.; Lima Filho, J.V. Vibrio spp. Control at Brine Shrimp, Artemia, Hatching and Enrichment. J. World Aquac. 2014, 45, 65–74. [Google Scholar] [CrossRef]
  69. Williams, R.R.; Bell, T.A.; Lightner, D.V. Shrimp Antimicrobial Testing. II. Toxicity Testing and Safety Determination for Twelve Antimicrobials with Penaeid Shrimp Larvae. J. Aquat. Anim. Health 1992, 4, 262–270. [Google Scholar] [CrossRef]
  70. Soto-Rodríguez, S.; Armenta, M.; Gómez-Gil, B. Effects of enrofloxacin and florfenicol on survival and bacterial population in an experimental infection with luminescent Vibrio campbellii in shrimp larvae of Litopenaeus vannamei. Aquaculture 2006, 255, 48–54. [Google Scholar] [CrossRef]
  71. Botelho, R.G.; Christofoletti, C.A.; Correia, J.E.; Ansoar, Y.; Olinda, R.A.; Tornisielo, V.L. Genotoxic responses of juvenile tilapia (Oreochromis niloticus) exposed to florfenicol and oxytetracycline. Chemosphere 2015, 132, 206–212. [Google Scholar] [CrossRef] [PubMed]
  72. Guo, R.; Zhang, Y.; Zhang, X.; Zhang, O.; Cheng, R.; Mostafizur, R.M.; Liu, Y. Effects of florfenicol exposure on growth, development and antioxidant capacity of flounder Paralichthys olivaceus larvae at different developmental stages. J. Ocean. Limnol. 2019. [Google Scholar] [CrossRef]
  73. Patra, S.K.; Mohamed, K.S. Enrichment of Artemia nauplii with the probiotic yeast Sacharomyces boulardii and its resistance against a pathogenic Vibrio. Aquac. Int. 2003, 11, 505–514. [Google Scholar] [CrossRef] [Green Version]
  74. Kalatzis, P.G.; Bastías, R.; Kokkari, C.; Katharios, P. Isolation and Characterization of Two Lytic Bacteriophages, φSt2 and φGrn1; Phage Therapy Application for Biological Control of Vibrio alginolyticus in Aquaculture Live Feeds. PLoS ONE. 2016, 11, e0151101. [Google Scholar] [CrossRef] [Green Version]
  75. Sotomayor, M.A.; Reyes, J.K.; Restrepo, L.; Domínguez-Borbor, C.; Maldonado, M.; Bayot, B. Efficacy assessment of commercially available natural products and antibiotics, commonly used for mitigation of pathogenic Vibrio outbreaks in Ecuadorian Penaeus (Litopenaeus) vannamei hatcheries. PLoS ONE 2019, 14, e0210478. [Google Scholar] [CrossRef]
  76. Gómez-Gil, B.; Thompson, F.; Thompson, C.C.; Swings, J. Vibrio rotiferianus sp nov., isolated from cultures of the rotifer Brachionus plicatilis. Int. J. Syst. Evol. Microbiol. 2003, 53, 239–243. [Google Scholar] [CrossRef] [Green Version]
  77. Pérez-Cataluña, A.; Lucena, T.; Tarazona, E.; Arahal, D.R.; Macián, M.C.; Pujalte, M.J. An MLSA approach for the taxonomic update of the Splendidus clade, a lineage containing several fish and shellfish pathogenic Vibrio spp. Syst. Appl. Microbiol. 2016, 39, 361–369. [Google Scholar] [CrossRef]
  78. Sawabe, T.; Ogura, Y.; Matsumura, Y.; Feng, G.; Gao, F.; Amin, A.K.M.; Mino, S.; Nakagawa, S.; Sawabe, T.; Kumar, R.; et al. Updating the Vibrio clades defined by multilocus sequence phylogeny: Proposal of eight new clades, and the description of Vibrio tritonius sp. nov. Front. Microbiol. 2013, 4, 414. [Google Scholar] [CrossRef] [Green Version]
  79. Al-Saari, N.; Gao, F.; Rohul, A.A.; Sato, K.; Sato, K.; Mino, S.; Suda, W.; Oshima, K.; Hattori, M.; Ohkuma, M.; et al. Advanced Microbial Taxonomy Combined with Genome-Based-Approaches Reveals that Vibrio astriarenae sp. nov., an Agarolytic Marine Bacterium, Forms a New Clade in Vibrionaceae. PLoS ONE 2015, 27, 10. [Google Scholar] [CrossRef] [Green Version]
  80. Schwarz, S.; Kehrenberg, C.; Doublet, B.; Cloeckaert, A. Molecular basis of bacterial resistance to chloramphenicol and florfenicol. FEMS Microbiol. Rev. 2004, 28, 519–542. [Google Scholar] [CrossRef] [Green Version]
  81. White, D.G.; Hudson, C.; Maurer, J.J.; Ayers, S.; Zhao, S.; Lee, M.D.; Bolton, L.; Foley, T.; Sherwood, J. Characterization of chloramphenicol and florfenicol resistance in Escherichia coli associated with bovine diarrhea. J. Clin. Microbiol. 2000, 38, 4593–4598. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  82. Singer, R.S.; Patterson, S.K.; Meier, A.E.; Gibson, J.K.; Lee, H.L.; Maddox, C.W. Relationship between phenotypic and genotypic florfenicol resistance in Escherichia coli. Antimicrob. Agents Chemother. 2004, 48, 4047–4049. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  83. Gordon, L.; Cloeckaert, A.; Doublet, B.; Schwarz, S.; Bouju-Albert, A.; Ganiere, J.P.; Le, B.H.; Le Fleche-Mateos, A.; Giraud, E. Complete sequence of the floR-carrying multiresistance plasmid pAB5S9 from freshwater Aeromonas bestiarum. J. Antimicrob. Chemother. 2008, 62, 65–71. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  84. Dang, H.; Zhang, X.; Song, L.; Chang, Y.; Yang, G. Molecular determination of oxytetracycline-resistant bacteria and their resistance genes from mariculture environments of China. J. Appl. Microbiol. 2007, 103, 2580–2592. [Google Scholar] [CrossRef]
  85. Kim, E.; Aoki, T. Sequence analysis of the florfenicol resistance gene encoded in the transferable R-plasmid from a fish pathogen, Pasteurella piscicida. Microbiol. Immunol. 1996, 40, 665–669. [Google Scholar] [CrossRef]
  86. Cloeckaert, A.; Baucheron, S.; Flaujac, G.; Schwarz, S.; Kehrenberg, C.; Martel, J.L.; Chaslus-Dancla, E. Plasmid-mediated florfenicol resistance encoded by the floR gene in Escherichia coli isolated from cattle. Antimicrob. Agents Chemother. 2000, 44, 2858–2860. [Google Scholar] [CrossRef] [Green Version]
  87. Cloeckaert, A.; Baucheron, S.; Chaslus-Dancla, E. Nonenzymatic chloramphenicol resistance mediated by IncC plasmid R55 is encoded by a floR gene variant. Antimicrob. Agents Chemother. 2001, 45, 2381–2382. [Google Scholar] [CrossRef] [Green Version]
  88. da Silva, G.C.; Rossi, C.C.; Santana, M.F.; Langford, P.R.; Bosse, J.T.; Bazzolli, D.M.S. p518, a small floR plasmid from a south American isolate of Actinobacillus pleuropneumoniae. Vet. Microbiol. 2017, 204, 129–132. [Google Scholar] [CrossRef]
  89. Lu, J.; Zhang, J.; Xu, L.; Liu, Y.; Li, P.; Zhu, T.; Cheng, C.; Lu, S.; Xu, T.; Yi, H.; et al. Spread of the florfenicol resistance floR gene among clinical Klebsiella pneumoniae isolates in China. Antimicrob. Resist. Infect. Cont. 2018, 7, 127. [Google Scholar] [CrossRef] [Green Version]
Figure 1. Chronology of the live-feed feeding regime during the larval stage of reared Genypterus chilensis and the sampling of live feeds during larval culture. Circles represent live-feed culture tanks deployed in the commercial hatchery. C: untreated cultures; T: florfenicol-treated cultures (20 mg/L). Arrows show the sampling times (dph).
Figure 1. Chronology of the live-feed feeding regime during the larval stage of reared Genypterus chilensis and the sampling of live feeds during larval culture. Circles represent live-feed culture tanks deployed in the commercial hatchery. C: untreated cultures; T: florfenicol-treated cultures (20 mg/L). Arrows show the sampling times (dph).
Animals 10 00505 g001
Figure 2. Culturable counts of heterotrophic bacteria (HB), florfenicol-resistant bacteria (FRB), and Vibrio spp. from untreated (control) and treated with florfenicol (20 mg/L) rotifer (a) and Artemia (b) cultures. * Significant difference (p < 0.05) between untreated and florfenicol-treated cultures.
Figure 2. Culturable counts of heterotrophic bacteria (HB), florfenicol-resistant bacteria (FRB), and Vibrio spp. from untreated (control) and treated with florfenicol (20 mg/L) rotifer (a) and Artemia (b) cultures. * Significant difference (p < 0.05) between untreated and florfenicol-treated cultures.
Animals 10 00505 g002
Figure 3. Antibacterial resistance of studied bacterial isolates recovered from rotifer (n = 27) and Artemia (n = 38) cultures used to feed Genypterus chilensis larvae. AMO: Amoxicillin; STR: Streptomycin; KAN: Kanamycin; FLO: Florfenicol; OXY: Oxytetracycline; OXA: Oxolinic acid; FLQ: Flumequine; SXT: Sulfamethoxazole-trimethoprim. * Significant difference (p < 0.05) between rotifer and Artemia cultures.
Figure 3. Antibacterial resistance of studied bacterial isolates recovered from rotifer (n = 27) and Artemia (n = 38) cultures used to feed Genypterus chilensis larvae. AMO: Amoxicillin; STR: Streptomycin; KAN: Kanamycin; FLO: Florfenicol; OXY: Oxytetracycline; OXA: Oxolinic acid; FLQ: Flumequine; SXT: Sulfamethoxazole-trimethoprim. * Significant difference (p < 0.05) between rotifer and Artemia cultures.
Animals 10 00505 g003
Table 1. Heterotrophic bacteria (HB), florfenicol-resistant bacteria (FRB), and Vibrio spp. in mass live-feed cultures used for rearing G. chilensis larvae.
Table 1. Heterotrophic bacteria (HB), florfenicol-resistant bacteria (FRB), and Vibrio spp. in mass live-feed cultures used for rearing G. chilensis larvae.
DayCultureGroupCulturable Counts ± SD (CFU/g)
Control CulturesTreated Cultures
1212
6RotiferHB7.90 × 108 ± 9.16 × 1075.80 × 108 ± 2.33 × 108N/AN/A
FRB1.03 × 107 ± 4.94 × 1068.29 × 106 ± 2.39 × 106N/AN/A
Vibrio3.04 × 108 ± 4.48 × 1071.48 × 108 ± 4.95 × 107N/AN/A
18RotiferHB2.21 × 108 ± 2.11 × 1082.57 × 108 ± 1.37 × 108N/AN/A
FRB8.03 × 104 ± 1.04 × 1045.20 × 105 ± 3.74 × 105N/AN/A
Vibrio3.29 × 107 ± 9.05 × 1063.08 × 107 ± 2.08 × 107N/AN/A
18ArtemiaHB4.21 × 108 ± 1.68 × 1083.09 × 108 ± 2.37 × 1083.81 × 108 ± 2.45 × 1081.58 × 108 ± 5.21 × 107
FRB1.57 × 107 ± 7.88 × 1061.47 × 106 ± 4.88 × 1043.82 × 107 ± 1.58 × 1077.84 × 107 ± 1.47 × 107
Vibrio1.62 × 107 ± 1.46 × 1073.60 × 104 ± 2.70 × 1041.82 × 107 ± 8.44 × 1064.42 × 106 ± 3.08 × 106
32RotiferHB6.79 × 108 ± 9.57 × 1071.71 × 109 ± 2.63 × 108N/AN/A
FRB1.12 × 106 ± 9.57 × 1051.79 × 107 ± 7.27 × 106N/AN/A
Vibrio8.33 × 107 ± 3.56 × 1072.63 × 108 ± 8.25 × 107N/AN/A
32ArtemiaHB4.55 × 108 ± 2.98 × 1081.74 × 109 ± 4.99 × 1081.27 × 109 ± 3.66 × 1081.21 × 109 ± 7.55 × 108
FRB3.33 × 107 ± 2.01 × 1071.00 × 108 ± 5.92 × 1071.22 × 108 ± 7.18 × 1073.50 × 108 ± 6.41 × 107
Vibrio1.20 × 107 ± 1.38 × 1073.54 × 108 ± 1.41 × 1082.14 × 106 ± 1.05 × 1074.02 × 107 ± 2.44 × 106
N/A: Not available.
Table 2. Identification, source, and phenotypic properties of florfenicol-resistant isolates recovered from rotifer cultures.
Table 2. Identification, source, and phenotypic properties of florfenicol-resistant isolates recovered from rotifer cultures.
IsolateSourcePhenotypic PropertiesAccession No.Closest Species (% Identity)
GramOF GlucoseOxidaseO-129Growth on TCBS
RVF24Treated cultureF+S+MN920721Vibrio azureus (100.00)
RVF27Untreated cultureF+S+MN920722Vibrio xuii (99.65)
RVF33Treated cultureF+S+MN920723Vibrio xuii (99.49)
RGF51Untreated cultureI+RMN920724Pseudoalteromonas carrageenovora (99.49)
RGF65Treated cultureI+RMN920725Pseudoalteromonas tetraodonis (90.81)
RGF67Treated cultureI+RMN920726Pseudoalteromonas paragorgicola (99.04)
RGF70Treated cultureI+RMN920727Pseudoalteromonas carrageenovora (99.15)
RGT71Untreated cultureF+S+MN920728Vibrio alginolyticus (98.97)
RGFR106Untreated cultureF+S+MN920729Vibrio xuii (98.56)
RGFR107Untreated cultureF+S+MN920730Vibrio xuii (98.25)
RGFR108Untreated cultureF+S+MN955424Vibrio xuii (98.01)
RGFR109Untreated cultureF+S+MN920731Vibrio xuii (98.60)
RGFR112Treated cultureF+S+MN920732Vibrio xuii (97.31)
RGFR113Treated cultureF+S+MN920733Vibrio xuii (97.91)
RGFR114Treated cultureF+S+MN920734Vibrio algoinfesta (97.08)
RGFR115Treated cultureF+S+MN920735Vibrio xuii (97.21)
RGFR116Treated cultureF+S+MN920736Vibrio xuii (97.95)
RGFR118Treated cultureF+S+MN920737Vibrio xuii (97.80)
RGFR119Treated cultureF+S+MN920738Vibrio xuii (97.23)
RGFR120Treated cultureF+S+MN920739Vibrio xuii (98.08)
RGFR121Treated cultureF+S+MN920740Vibrio xuii (97.65)
RGTR139Untreated cultureF+S+MN920741Vibrio xuii (99.36)
RGTR146Untreated cultureF+S+MN920742Vibrio xuii (99.48)
RGTR150Treated cultureF+S+MN920743Vibrio algoinfesta (99.78)
RGTR154Treated cultureF+S+MN920744Vibrio xuii (98.45)
RGTR157Treated cultureF+S+MN920745Vibrio xuii (98.55)
RGTR160Treated cultureF+S+MN920746Vibrio xuii (99.54)
OF: Oxidation/Fermentation; O-129: 2,4-diamino-6,7-diisopropylpteridine; TCBS: Thiosulphate Citrate Bile Salt Agar; F: Fermenter; S: Susceptible; R: Resistant.
Table 3. Identification, source, and phenotypic properties of florfenicol-resistant isolates recovered from Artemia cultures.
Table 3. Identification, source, and phenotypic properties of florfenicol-resistant isolates recovered from Artemia cultures.
IsolateSourcePhenotypic PropertiesAccession No.Closest Species (% Identity)
GramOF GlucoseOxidaseO-129Growth on TCBS
AVF09Untreated cultureF+S+MN920747Vibrio tasmaniensis (99.57)
AVF32Untreated cultureF+S+MN920748Vibrio alginolyticus (99.53)
AVF45Untreated cultureF+S+MN920749Vibrio toranzoniae (99.72)
AVF53Untreated cultureF+S+MN920750Vibrio rotiferianus (95.90)
AVF58Untreated cultureF+S+MN920751Vibrio rotiferianus (95.90)
AVF60Untreated cultureF+S+MN920752Vibrio neocaledonicus (100.00)
AVF61Untreated cultureF+S+MN920753Vibrio harveyi (100.00)
AVF68Untreated cultureF+S+MN920754Vibrio toranzoniae (99.14)
AGF75Untreated cultureF+S+MN920755Vibrio natriegens (98.35)
AGF78Untreated cultureO+RMN920756Pseudomonas pachastrellae (98.14)
AGF82Untreated cultureF+S+MN920758Vibrio alginolyticus (100.00)
AGF83Untreated cultureF+S+MN920760Vibrio alginolyticus (99.90)
AGF85Untreated cultureF+S+MN920773Vibrio alginolyticus (99.89)
AGF86Untreated cultureF+S+MN920759Vibrio neocaledonicus (97,62)
AGF100Treated cultureF+S+MN920757Vibrio parahaemolyticus (100.00)
AGF101Treated cultureF+S+MN920774Vibrio natriegens (100.00)
AGF104Untreated cultureF+S+MN920775Vibrio alginolyticus (100.00)
AGF105Untreated cultureF+S+MN920776Vibrio natriegens (99.69)
AGT90Untreated cultureO+RMN920761Pseudoalteromonas ganghwensis (99.69)
AGT92Untreated cultureO+RMN920777Pseudoalteromonas tetraodonis (94.08)
AGT93Untreated cultureO+RMN920766Psychrobacter pacificensis (83.80)
AGT94Untreated cultureO+RMN920767Pseudoalteromonas atlantica (98.05)
AGT103Untreated cultureF+S+MN920778Vibrio neocaledonicus (99.90)
AGT104Untreated cultureO+RMN920779Pseudoaleteromonas carrageenovora (85.03)
AGT106Untreated cultureI+RMN955425Pseudoalteromonas shioyasakiensis (97.20)
AGT109Treated cultureF+S+MN920780Vibrio hyugaensis (98.30)
AGT110Treated cultureF+S+MN920768Vibrio alginolyticus (97.24)
AGT111Treated cultureF+S+MN920783Vibrio xuii (97.64)
AGT112Treated cultureF+S+MN920765Vibrio alginolyticus (99.80)
AGT114Treated cultureF+S+MN920764Vibrio neocaledonicus (99.60)
AGT119Untreated cultureF+S+MN920763Vibrio parahaemolyticus (99.30)
AGT122Treated cultureF+S+MN920769Vibrio azureus (98.29)
AGT123Treated cultureF+S+MN920770Vibrio diabolicus (99.90)
AGT124Treated cultureF+S+MN920771Vibrio alginolyticus (99.79)
AGT125Treated cultureF+S+MN920772Vibrio alginolyticus (98.65)
AGT127Treated cultureO+RMN920781Pseudoalteromonas tetraodonis (86.82)
AGT128Treated cultureF+S+MN920782Vibrio alginolyticus (98.23)
AGT129Treated cultureF+S+MN920762Vibrio parahaemolyticus (97.71)
OF: Oxidation/Fermentation; O-129: 2,4-diamino-6,7-diisopropylpteridine; TCBS: Thiosulphate Citrate Bile Salt Agar; F: Fermenter; S: Susceptible; R: Resistant.
Table 4. Minimum inhibitory concentrations (MICs) of florfenicol (FLO), antimicrobial resistance patterns, florfenicol-resistance-encoding genes, and plasmid content of resistant isolates recovered from rotifer cultures.
Table 4. Minimum inhibitory concentrations (MICs) of florfenicol (FLO), antimicrobial resistance patterns, florfenicol-resistance-encoding genes, and plasmid content of resistant isolates recovered from rotifer cultures.
IsolateMIC FLO (µg/mL)Resistance PatternFLO Resistance GenesNo. of PlasmidsApproximate Size (kb)
floRfexA
RVF2464AMO-STR-KAN-FLO-OXY-OXA-FLQ0
RVF2764AMO-STR-KAN-FLO-OXY-OXA-FLQ-SXT+0
RVF3332AMO-STR-KAN-FLO-OXY-OXA-FLQ-SXT0
RGF51256FLO-OXY++0
RGF65256FLO-OXY-OXA-FLQ-SXT++11.4
RGF67256FLO-OXY0
RGF70256FLO-OXA0
RGT71128AMO-STR-KAN-FLO-OXY+240/60
RGFR106256STR-KAN-FLO-OXA-FLQ-SXT+140
RGFR107256STR-KAN-FLO-OXY-OXA-FLQ-SXT++0
RGFR108512STR-KAN-FLO-OXY-OXA-FLQ-SXT0
RGFR109256STR-KAN-FLO-OXY-OXA-FLQ-SXT+0
RGFR112256STR-KAN-FLO-OXY-OXA-FLQ-SXT+140
RGFR113256STR-KAN-FLO-OXY-OXA-FLQ-SXT+0
RGFR114256STR-KAN-FLO-OXY-OXA-FLQ-SXT+140
RGFR115256AMO-STR-KAN-FLO-OXY-OXA-FLQ-SXT+180
RGFR116256STR-KAN-FLO-OXY-OXA-FLQ-SXT+140
RGFR118128STR-KAN-FLO-OXY-OXA-FLQ-SXT+140
RGFR119256AMO-STR-KAN-FLO-OXY-OXA-FLQ-SXT+0
RGFR120256STR-KAN-FLO-OXY-OXA-FLQ-SXT+0
RGFR121512STR-FLO-OXY-OXA-FLQ-SXT+135
RGTR139128STR-FLO-OXY-OXA-FLQ-SXT+0
RGTR146512STR-KAN-FLO-OXY-OXA-FLQ-SXT+140
RGTR150256STR-KAN-FLO-OXY-OXA-FLQ-SXT+140
RGTR154256STR-KAN-FLO-OXY-OXA-FLQ-SXT+140
RGTR157256STR-KAN-FLO-OXY-OXA-FLQ-SXT+140
RGTR160256STR-KAN-FLO-OXY-OXA-FLQ-SXT+135
AMO: Amoxicillin; STR: Streptomycin; KAN: Kanamycin; FLO: Florfenicol; OXY: Oxytetracycline; OXA: Oxolinic acid; FLQ: Flumequine; SXT: Sulfamethoxazole-trimethoprim.
Table 5. Minimum inhibitory concentrations (MICs) of florfenicol (FLO), antimicrobial resistance patterns, florfenicol-resistance-encoding genes, and plasmid content of resistant isolates recovered from Artemia cultures.
Table 5. Minimum inhibitory concentrations (MICs) of florfenicol (FLO), antimicrobial resistance patterns, florfenicol-resistance-encoding genes, and plasmid content of resistant isolates recovered from Artemia cultures.
IsolateMIC FLO (µg/mL)Resistance PatternFLO Resistance Genes No. of PlasmidsApproximate Size (kb)
floRfexA
AVF0932AMO-STR-FLO-OXY-OXA-FLQ+140
AVF3232STR-FLO0
AVF4532STR-KAN-FLO-OXY35/6/15
AVF5332AMO-STR-KAN-FLO-OXY-SXT140
AVF5864AMO-STR-KAN-FLO-OXY-OXA-FLQ-SXT+140
AVF6032AMO-STR-KAN-FLO-OXY-OXA-FLQ-SXT140
AVF6164AMO-STR-KAN-FLO-OXY-OXA-SXT+140
AVF68512STR-KAN-FLO-OXY-OXA140
AGF75512AMO-STR-FLO-OXY-SXT+235/100
AGF78256STR-KAN-FLO-OXY-OXA-FLQ-SXT+0
AGF82512AMO-STR-KAN-FLO-OXY-SXT+135
AGF83512AMO-STR-KAN-FLO-OXY-SXT+140
AGF85512AMO-STR-KAN-FLO-OXY-SXT+135
AGF86512AMO-STR-KAN-FLO-SXT+150
AGF100256AMO-STR-KAN-FLO-SXT+0
AGF101256AMO-STR-KAN-FLO-SXT+135
AGF104256AMO-STR-KAN-FLO-OXA-FLQ-SXT+135
AGF1051024AMO-STR-FLO-OXY-SXT+235/100
AGT90256STR-KAN-FLO-OXY-SXT140
AGT921024STR-KAN-FLO-OXY-OXA-FLQ-SXT0
AGT93128AMO-STR-FLO-OXY-SXT+140
AGT941024AMO-STR-KAN-FLO-OXY-SXT150
AGT103512AMO-STR-KAN-FLO-OXY-SXT+135
AGT104128STR-FLO-OXY-OXA-FLQ+150
AGT106256STR-KAN-FLO-OXY-SXT150
AGT109512AMO-STR-KAN-FLO-OXY-SXT++235/100
AGT110128AMO-STR-FLO-OXY-SXT+215/45
AGT1111024STR-KAN-FLO-OXY-OXA-FLQ-SXT+21.3/2
AGT112256AMO-STR-KAN-FLO-OXY-SXT+155
AGT114128AMO-STR-FLO-OXY-SXT+215/45
AGT119256AMO-STR-FLO-OXY-SXT+215/45
AGT122512AMO-STR-FLO-OXY-SXT+215/45
AGT123256AMO-STR-KAN-FLO-OXY-SXT+240/60
AGT124128AMO-STR-FLO-OXY-SXT+240/60
AGT125256AMO-STR-KAN-FLO-OXY-SXT+150
AGT127512AMO-STR-KAN-FLO-OXY-SXT21/40
AGT128256AMO-STR-KAN-FLO-OXY-SXT+135
AGT129512AMO-STR-KAN-FLO-OXY-SXT+135
AMO: Amoxicillin; STR: Streptomycin; KAN: Kanamycin; FLO: Florfenicol; OXY: Oxytetracycline; OXA: Oxolinic acid; FLQ: Flumequine; SXT: Sulfamethoxazole-trimethoprim.

Share and Cite

MDPI and ACS Style

Hurtado, L.; Miranda, C.D.; Rojas, R.; Godoy, F.A.; Añazco, M.A.; Romero, J. Live Feeds Used in the Larval Culture of Red Cusk Eel, Genypterus chilensis, Carry High Levels of Antimicrobial-Resistant Bacteria and Antibiotic-Resistance Genes (ARGs). Animals 2020, 10, 505. https://doi.org/10.3390/ani10030505

AMA Style

Hurtado L, Miranda CD, Rojas R, Godoy FA, Añazco MA, Romero J. Live Feeds Used in the Larval Culture of Red Cusk Eel, Genypterus chilensis, Carry High Levels of Antimicrobial-Resistant Bacteria and Antibiotic-Resistance Genes (ARGs). Animals. 2020; 10(3):505. https://doi.org/10.3390/ani10030505

Chicago/Turabian Style

Hurtado, Luz, Claudio D. Miranda, Rodrigo Rojas, Félix A. Godoy, Mark A. Añazco, and Jaime Romero. 2020. "Live Feeds Used in the Larval Culture of Red Cusk Eel, Genypterus chilensis, Carry High Levels of Antimicrobial-Resistant Bacteria and Antibiotic-Resistance Genes (ARGs)" Animals 10, no. 3: 505. https://doi.org/10.3390/ani10030505

APA Style

Hurtado, L., Miranda, C. D., Rojas, R., Godoy, F. A., Añazco, M. A., & Romero, J. (2020). Live Feeds Used in the Larval Culture of Red Cusk Eel, Genypterus chilensis, Carry High Levels of Antimicrobial-Resistant Bacteria and Antibiotic-Resistance Genes (ARGs). Animals, 10(3), 505. https://doi.org/10.3390/ani10030505

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop